MaSS - Maastricht Sarcopenia Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

247 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this cross-sectional study is to obtain insight in the characteristics (nutritional status and level of physical activity) of sarcopenic compared to non-sarcopenic community-dwelling older people. There is one measurement moment and measurements will take place at the participant's home.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

NCT07201831

Metabolic Dysfunction-associated Steatohepatitis (MASH)

ENROLLING_BY_INVITATION

Metabolic Phenotyping in Humans

NCT01298375

Healthy Obesity Type 2 Diabetes Mellitus

UNKNOWN

Serum Concentrations, Physical and Psychological Well-being in Metabolic Syndrome

NCT03338868

Metabolic Syndrome

UNKNOWN

Study of How Exercise or Weight Loss Effects Metabolic Syndrome

NCT00292994

Metabolic Syndrome Insulin Resistance Obesity

UNKNOWN NA

Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study

NCT03058016

Metabolic Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Characterization of sarcopenic older people (demographics, nutritional status, level of physical activity)
* Prevalence rates of sarcopenia in community-dwelling older people in the Netherlands
* Insight in differences and/or overlap between sarcopenia versus frailty
* Insight in the impact of sarcopenia on economic outcomes

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sarcopenic vs. non-sarcopenic

Participants are classified as sarcopenic/non-sarcopenic according to the criteria of the European Working Group of Sarcopenia in Older People (EWGSOP).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 65 years old
* Have given informed consent
* Understand Dutch language
* Able to perform a walk test

Exclusion Criteria

* Older people living in a nursing home
* Older people with active rheumatoid arthritis, post stroke status with evident lingering symptoms (paralysis, loss of motor functions), diseases of the nervous system like Parkinson and MS, active angina pectoris, dementia
* Older people in a wheelchair, with ICD or pacemaker

Minimum Eligible Age

65 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes